Key facts
- Corteva cut full-year adjusted profit guidance to 76 to 80 cents a share from $3.60 to $3.80.
- Corteva guided 2026 adjusted EBITDA to $1.1 billion to $1.125 billion.
- Analysts on average estimated EBITDA of $1.82 billion and adjusted profit of $1.63 a share, per LSEG data.
- Corteva said farmer liquidity constraints, higher financing costs, just-in-time purchasing and pricing pressure softened Brazil more than expected.
- Oppenheimer analyst Kristen Owen said Corteva stumbled out of the gate in its first standalone earnings report.
- Morningstar analyst Seth Goldstein said Corteva's results would be more volatile after the spinoff due to crop protection cyclicality.
Corteva cut its full-year adjusted profit forecast to 76 to 80 cents a share from $3.60 to $3.80 on November 12, 2026, citing continued weakness in Brazilian markets. The US agrichemicals company, which makes crop protection products such as herbicides and fungicides, said farmer liquidity constraints, higher financing costs, just-in-time purchasing and increased pricing pressure produced a significantly softer market in Brazil than it had anticipated.
Corteva shares fell 22.8% to $9.36 on November 12, 2026, their lowest in a year, and were on track for their steepest percentage loss on record, according to Reuters.
The company guided 2026 adjusted earnings before interest, taxes, depreciation and amortization to $1.1 billion to $1.125 billion. Analysts on average estimated EBITDA of $1.82 billion and adjusted profit of $1.63 a share for the year, according to data compiled by LSEG.
Earlier in 2026, Corteva completed the separation of its seed and genetics business into a separately traded company, Vylor. Oppenheimer analyst Kristen Owen said: "Corteva stumbled out of the gate in its first standalone earnings report." Morningstar analyst Seth Goldstein said that following the spinoff, "we expect Corteva's results to be more volatile due to the cyclicality of the crop protection market."